Status:
COMPLETED
The Efficacy of Amnion Chorion Allograft in Management of Gingival Recession.
Lead Sponsor:
Minia University
Conditions:
Gingival Recession, Localized
Eligibility:
All Genders
25-45 years
Phase:
PHASE4
Brief Summary
the main goal of this clinical trial is to test the efficacy of amnion Chorion allograft in managing gingival recession. The main questions it aims to answer are: Is it effective in treating gingival ...
Detailed Description
Gingival recession (GR) is characterized by apical migration of soft tissue margin beyond the cemento-enamel junction (CEJ) or the platform of an implant. Gingival recession is a common daily finding...
Eligibility Criteria
Inclusion
- Selected patients of both sexes are 25-45 years old.
- Patients are systemically healthy based on the questionnaire dental modification of the Cornell index.
- O'Leary index (1972) is less than 10% (the surgical therapy is not initiated until the patient reaches the 10% level or less of plaque accumulation).
- Buccal recession defects are classified RT1 according to Cairo's classification (2011).
- Clinical indication and/or patient request for recession coverage.
Exclusion
- RT2 and RT3 recession defects.
- Pregnant female.
- Smokers.
- Patients with special needs or with any mental problems.
- All patients are using any kind of medication that could interfere with the healing of periodontal tissues. Such as chemotherapy and radiotherapy.
- Teeth with root carious lesions.
- Rotated and extruded teeth.
- Patients underwent any prior periodontal surgery in the relevant region.
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 22 2025
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT06508476
Start Date
August 1 2024
End Date
March 22 2025
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
faculty of dentistry, Minia University
Minya, Other, Egypt, 61111